Harris Siddiqi

Title(s)BLANK AST 2, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A prospective study on the prevalence of at-risk MASH in patients with type 2 diabetes mellitus in the United States. Aliment Pharmacol Ther. 2024 Apr 08. Mittal N, Siddiqi H, Madamba E, Richards L, Bettencourt R, Ajmera V, Loomba R. PMID: 38586922.
      View in: PubMed   Mentions:
    2. Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction-associated steatotic liver disease. Aliment Pharmacol Ther. 2024 Apr 03. Noureddin N, Huang DQ, Bettencourt R, Siddiqi H, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Gidener T, Allen AM, Ajmera V, Loomba R. PMID: 38571305.
      View in: PubMed   Mentions:    Fields:    
    3. MASH Resolution Index: development and validation of a non-invasive score to detect histological resolution of MASH. Gut. 2024 Feb 28. Loomba R, Amangurbanova M, Bettencourt R, Madamba E, Siddiqi H, Richards L, Behling C, Sirlin CB, Gottwald MD, Feng S, Margalit M, Huang DQ. PMID: 38418210.
      View in: PubMed   Mentions:    Fields:    
    4. Cost-Effectiveness Analysis of Hepatocellular Carcinoma Surveillance in Nonalcoholic Fatty Liver Disease Cirrhosis Using US Visualization Score C-Triggered Abbreviated MRI. Am J Gastroenterol. 2024 Feb 05. Mulgaonkar A, Huang DQ, Siddiqi H, Fowler K, Sirlin CB, Marks R, Loomba R, Konijeti GG. PMID: 38146873.
      View in: PubMed   Mentions:    Fields:    
    5. Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality. Aliment Pharmacol Ther. 2024 Jan; 59(1):80-88. Lee SW, Huang DQ, Bettencourt R, Ajmera V, Tincopa M, Noureddin N, Amangurbanova M, Siddiqi H, Madamba E, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Nakajima A, Yoneda M, Idilman R, Gumussoy M, Oz DK, Erden A, Loomba R. PMID: 37968251; PMCID: PMC10807727.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. MEFIB-Index and MAST-Score in the assessment of hepatic decompensation in metabolic dysfunction-associated steatosis liver disease-Individual participant data meta-analyses. Aliment Pharmacol Ther. 2023 11; 58(9):856-865. Noureddin N, Ajmera V, Bergstrom J, Bettencourt R, Huang DQ, Siddiqi H, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Loomba R. PMID: 37694993; PMCID: PMC10901230.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Clinical utility of liver fat quantification for determining cardiovascular disease risk among patients with type 2 diabetes. Aliment Pharmacol Ther. 2023 09; 58(6):585-592. Kuo SZ, Cepin S, Bergstrom J, Siddiqi H, Jung J, Lopez S, Huang DQ, Taub P, Amangurbanova M, Loomba R. PMID: 37431679; PMCID: PMC10792531.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis. Lancet Gastroenterol Hepatol. 2023 09; 8(9):829-836. Huang DQ, Noureddin N, Ajmera V, Amangurbanova M, Bettencourt R, Truong E, Gidener T, Siddiqi H, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Yoneda M, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Allen AM, Noureddin M, Loomba R. PMID: 37419133; PMCID: PMC10812844.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    9. Development and Validation of the Nonalcoholic Fatty Liver Disease Familial Risk Score to Detect Advanced Fibrosis: A Prospective, Multicenter Study. Clin Gastroenterol Hepatol. 2024 01; 22(1):81-90.e4. Huang DQ, Ahlholm N, Luukkonen PK, Porthan K, Amangurbanova M, Madamba E, Bettencourt R, Siddiqi H, Cervantes V, Hernandez C, Lopez SJ, Richards L, Nemes K, Isoniemi H, Yki-Järvinen H, Loomba R. PMID: 37406954.
      View in: PubMed   Mentions: 2     Fields:    
    10. Occurrence and Management Strategies for Catheter Entrapment with Onyx Liquid Embolization. J Vasc Interv Neurol. 2015 Jul; 8(3):37-41. Qureshi AI, Mian N, Siddiqi H, Qureshi MH, Malik AM, Rauf Afzal M, Khan AA, Suri MF. PMID: 26301030; PMCID: PMC4535605.
      View in: PubMed   Mentions: 7  
    11. "No turn back approach" to reduce treatment time for endovascular treatment of acute ischemic stroke. J Stroke Cerebrovasc Dis. 2014 May-Jun; 23(5):e317-23. Qureshi AI, Egila H, Adil MM, Siddiqi H, Mian N, Hassan AE, Miley JT, Rodriguez GJ, Suri MF. PMID: 24560249.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans